MediciNova, Inc.
(NASDAQ : MNOV)

( )
MNOV After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.66%196.941.3%$565.97m
GILDGilead Sciences, Inc.
0.70%66.420.9%$368.71m
BIIBBiogen Inc.
1.35%238.791.3%$340.32m
ILMNIllumina, Inc.
1.43%309.573.5%$338.07m
ALXNAlexion Pharmaceuticals, Inc.
0.62%106.322.0%$332.28m
CELGCelgene Corporation
0.42%99.371.3%$309.99m
REGNRegeneron Pharmaceuticals, Inc.
3.40%295.872.6%$188.33m
VRTXVertex Pharmaceuticals Incorporated
1.12%178.121.9%$186.01m
AAgilent Technologies, Inc.
-0.18%77.931.6%$185.14m
EXASExact Sciences Corporation
0.55%103.9724.1%$152.91m
SRPTSarepta Therapeutics, Inc.
-3.34%82.5114.6%$139.60m
ACADACADIA Pharmaceuticals Inc.
-2.26%40.7413.9%$129.03m
INCYIncyte Corporation
3.96%81.212.5%$93.98m
ALDRAlder Biopharmaceuticals, Inc.
-0.11%18.6410.2%$81.98m
BMRNBioMarin Pharmaceutical Inc.
-1.38%74.954.3%$76.08m

Company Profile

MediciNova, Inc. is a biopharmaceutical company. It is engaged in acquiring and developing novel, small molecule therapeutics for the treatment of serious diseases for the treatment of diseases with unmet medical need. The firm's development pipeline consists of clinical-stage compounds for the treatment of acute exacerbations of asthma and COPD, progressive multiple sclerosis, methamphetamine addiction, neuropathic pain, asthma, interstitial cystitis, and solid tumor cancers. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA.